These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 37196706

  • 21. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I, Pérez Manghi F, García-Hernández P, Norwood P, Lehmann L, Tarp-Johansen MJ, Buse JB, DUAL V Investigators.
    JAMA; 2016 Mar 01; 315(9):898-907. PubMed ID: 26934259
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A, Bozzetto L, Franco L, Riccardi G, Rivellese AA, Annuzzi G.
    Nutr Metab Cardiovasc Dis; 2019 Oct 01; 29(10):1110-1117. PubMed ID: 31371264
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study.
    Mast R, Danielle Jansen AP, Walraven I, Rauh SP, van der Heijden AA, Heine RJ, Elders PJ, Dekker JM, Nijpels G, Hugtenburg JG.
    Eur J Endocrinol; 2016 May 01; 174(5):563-71. PubMed ID: 26837781
    [Abstract] [Full Text] [Related]

  • 27. Effects of obesity on metabolic and cardiovascular outcomes following insulin initiation in patients with type 2 diabetes.
    Anyanwagu U, Mamza J, Donnelly R, Idris I.
    Obes Res Clin Pract; 2018 May 01; 12(1):72-84. PubMed ID: 28939465
    [Abstract] [Full Text] [Related]

  • 28. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.
    Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P.
    Cardiovasc Diabetol; 2009 Feb 16; 8():9. PubMed ID: 19220880
    [Abstract] [Full Text] [Related]

  • 29. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
    Meneghini LF, Dornhorst A, Sreenan S, PREDICTIVE Study Group.
    Curr Med Res Opin; 2009 Apr 16; 25(4):1029-35. PubMed ID: 19281426
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical outcomes and resource use after 24 months of insulin therapy in Turkish patients with type 2 diabetes: subgroup analysis of the TREAT study.
    Oguz A, Cevizci E, Ertekin A, Abdulnabi R, Turkish TREAT Investigators.
    Int J Clin Pract; 2015 May 16; 69(5):588-96. PubMed ID: 25472768
    [Abstract] [Full Text] [Related]

  • 32. Clinical Determinants of Diabetes Progression in Multiethnic Asians with Type 2 Diabetes - A 3-Year Prospective Cohort Study.
    Liu S, Liu JJ, Gurung RL, Chan C, Yeo D, Ang K, Tang WE, Tavintharan S, Sum CF, Lim SC.
    Ann Acad Med Singap; 2019 Jul 16; 48(7):217-223. PubMed ID: 31495867
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus.
    Chen J, Borra S, Fan L, Huang A, Patel D, Juneja R.
    J Diabetes Complications; 2021 Oct 16; 35(10):107995. PubMed ID: 34364779
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
    Li CJ, Li J, Zhang QM, Lv L, Chen R, Lv CF, Yu P, Yu DM.
    Cardiovasc Diabetol; 2012 Nov 15; 11():142. PubMed ID: 23153177
    [Abstract] [Full Text] [Related]

  • 37. Factors associated with insulin-induced weight gain in an Australian type 2 diabetes outpatient clinic.
    Yadgar-Yalda R, Colman PG, Fourlanos S, Wentworth JM.
    Intern Med J; 2016 Jul 15; 46(7):834-9. PubMed ID: 27130246
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus.
    Sheu WH, Park SW, Gong Y, Pinnetti S, Bhattacharya S, Patel S, Seck T, Woerle HJ.
    Curr Med Res Opin; 2015 Mar 15; 31(3):503-12. PubMed ID: 25629790
    [Abstract] [Full Text] [Related]

  • 40. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N.
    Clin Ther; 2015 Mar 01; 37(3):574-84. PubMed ID: 25626486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.